T-COVRIX Trademark

Trademark Overview


On Tuesday, November 25, 2025, a trademark application was filed for T-COVRIX with the United States Patent and Trademark Office. The USPTO has given the T-COVRIX trademark a serial number of 99515352. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 21, 2026. This trademark is owned by ImmunityBio, Inc.. The T-COVRIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases; Medicinal preparations for the treatment and prevention of cancer and infectious diseases in the nature of coronavirus for administration as a vaccine; Pharmaceutical preparations for the prevention of infectious diseases in the nature of coronavirus for administration as a vaccine; Pharmaceutical preparations for the treatment of cancer and coronavirus for administration as a vaccine; Pharmaceutical preparations for the prevention of cancer and coronavirus for administration as a vaccine; Biological preparations for the prevention and treatment of cancer and infectious diseases in the nature of coronavirus for administration as a vaccine
t-covrix

General Information


Serial Number99515352
Word MarkT-COVRIX
Filing DateTuesday, November 25, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases; Medicinal preparations for the treatment and prevention of cancer and infectious diseases in the nature of coronavirus for administration as a vaccine; Pharmaceutical preparations for the prevention of infectious diseases in the nature of coronavirus for administration as a vaccine; Pharmaceutical preparations for the treatment of cancer and coronavirus for administration as a vaccine; Pharmaceutical preparations for the prevention of cancer and coronavirus for administration as a vaccine; Biological preparations for the prevention and treatment of cancer and infectious diseases in the nature of coronavirus for administration as a vaccine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 25, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Trademark Events


Event DateEvent Description
Tuesday, November 25, 2025NEW APPLICATION ENTERED
Tuesday, November 25, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, November 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 13, 2026ASSIGNED TO EXAMINER
Wednesday, March 18, 2026NON-FINAL ACTION WRITTEN
Wednesday, March 18, 2026NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 18, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 18, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 18, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 22, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 15, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2026PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED